Skip to main content
Log in

Achievements and prospects in the creation of antiaggregative drugs (Review)

  • Search for New Drugs
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Conclusion

Achievements in medicinal chemistry and pharmacology in studying the mechanisms of action of antiaggregants provide a deeper insight into the physicochemical backgrounds of phenomena involved in thrombocyte aggregation and provide controls for these processes using inductors and inhibitors of aggregation.

The information gained from experiments indicates the promising directions in the search for new, more efficient antithrombotic drugs. Good prospects are also related to the synthesis and search for inhibitors of various anzymes controlling the energetics of thrombocytes and capable of affecting their functional activity.

At present, a number of compounds capable of inhibiting the reactions of serotonin, fibrinogen, and thrombin, and combinations of serotonin and thromboxan inhibitors, are in various stages of characterization and implementation into practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M. A. Packman,Thromb. Haemostasis,50, 610–619 (1983).

    Google Scholar 

  2. S. Sherry,J. Int. Med. Res.,229, 111–116 (1991).

    Google Scholar 

  3. M. D. Mashkovskii,Drugs [in Russian], Part II, Meditsina, Moscow (1993).

    Google Scholar 

  4. v. A. Makarov,Farmakol. Toksikol.,52(4), 9–13 (1989).

    PubMed  CAS  Google Scholar 

  5. I. N. Bokarev,Ter. Arkhiv,64(10), 101–105 (1992).

    CAS  Google Scholar 

  6. J. R. O'Brien,Lancet,1, 779–782 (1968).

    Article  PubMed  Google Scholar 

  7. M. B. Zucker and J. Peterson,Proc. Soc. Exp. Biol. Med.,127, 547–551 (1968).

    PubMed  CAS  Google Scholar 

  8. B. Loucka,Sci. Pharm.,37(9), 416–420 (1988).

    CAS  Google Scholar 

  9. J. A. G. Reilly and G. A. Fitzgerald,Drugs,35, 154–176 (1988).

    PubMed  CAS  Google Scholar 

  10. J. Webster and A. S. Douglas,Blood Rev.,1(1), 9–20 (1987).

    Article  PubMed  CAS  Google Scholar 

  11. J. Vane,Monthly Nature,367, 215–216 (1994).

    Article  CAS  Google Scholar 

  12. D. Sciftede, A. Klee, K. Meithimann,Abstracts of the 3rd Erfurt Workshop on Platelets, Erfurt (1989), Abstr. 44.

  13. J. J. Thebault, J. Chick, and H. Caplain,Abstracts of the 3rd International Conference on Drug Absorption, Edinburgh (1988), Abstr. 98.

  14. T. Meade,Am. J. Cardiol.,65(6), 7–11 (1990).

    Article  Google Scholar 

  15. French Patent No. 8903138;Chem. Abstr., 902 (1990).

  16. N. Desideri, I. Sestili, P. Piccardoni, et al.,Arch. Pharm.,325(12), 773–777 (1992).

    CAS  Google Scholar 

  17. F. Doranden,Lyon Pharm.,42(2), 137–147 (1991).

    Google Scholar 

  18. F. Vaghi, M. Colombo, L. Pierucci, et al.,Drug. Exp. Clin. Res., No. 6, 249–260 (1993).

    Google Scholar 

  19. V. Coto, T. Picano, M. Cocorra, et al.,Rass. Med. Sper.,38(11–12), 237–243 (1991).

    Google Scholar 

  20. E. Ohshima, H. Takami, H. Harakawa, et al.,J. Med. Chem.,36(3), 417–420 (1993).

    Article  PubMed  CAS  Google Scholar 

  21. Sh. S. Bradwat, C. Cude, D. S. Cohen, et al.,J. Med. Chem.,36, 205–209 (1993).

    Article  Google Scholar 

  22. K. M. Lakin, V. A. Makarov, N. V. Novikova, et al.,Farmakol. Toksikol.,46(3), 113–125 (1983).

    PubMed  CAS  Google Scholar 

  23. N. Kieffer and D. R. Philips,Ann. Rev. Cell. Biol.,6, 329–357 (1990).

    Article  PubMed  CAS  Google Scholar 

  24. P. C. Zamecnik, J. M. G. Kim, G. Taylor, et al.,Proc. Nat. Acad. Sci. USA,89(6), 2370–2373 (1992).

    Article  PubMed  CAS  Google Scholar 

  25. I. S. Severina,Byull. Eksp. Biol. Med.,3, 230–235 (1995).

    Google Scholar 

  26. T. W. Ku, W. H. Miller, W. E. Bondinelli, et al.,J. Med. Chem.,35, 2040–2048 (1992).

    Article  Google Scholar 

  27. P. L. Barker, S. Bullens, S. Bunting, et al.,J. Med. Chem.,38, 9–12 (1995).

    Article  Google Scholar 

  28. H. K. Gold, B. S. Collar, T. Jasuda, et al.,Circulation,77, 670–677 (1988).

    PubMed  CAS  Google Scholar 

  29. M. Pfaff, M. A. McLane, L. Beviglia, et al.,Cell. Adhes. Commun.,2, 491–501 (1994).

    PubMed  CAS  Google Scholar 

  30. M. A. McLane, M. A. Kowalska, L. Silver, et al.,Biochem. J.,301, 429–436 (1994).

    PubMed  CAS  Google Scholar 

  31. J. Williams, B. Rucinski, J. C. Holl, et al.,Biochem. Biophys. Acta,1039, 81–89 (1990).

    PubMed  CAS  Google Scholar 

  32. M. Gurrath, G. Muller, H. Kessler, et al.,Eur. J. Biochem.,210, 911–921 (1992).

    Article  PubMed  CAS  Google Scholar 

  33. US Patent No. 4857509;Ref. Zh. VNIIPI, Izobret. Stran Mira, No. 15(11), (1990).

  34. E. P. Plow and M. H. Ginsberg,Cell. Adhes.,9, 117–156 (1989).

    CAS  Google Scholar 

  35. S. A. Andronati, V. M. Kabanov, T. L. Karaseva, et al.,Proceedings of the 23rd European Peptide Symposium, Peptides, ESCOM, (1994), p. 382.

  36. J. A. Zablocki, J. G. Rico, R. B. Garland, et al.,J. Med. Chem.,38(13), 2378–2393 (1995).

    Article  PubMed  CAS  Google Scholar 

  37. M. Camini and L. Evangelisti,Minerva Med.,83(9), 525–528 (1992).

    Google Scholar 

  38. A. I. Soloview and P. Braquet,Int. Union Physiol. Sci.,7, 166–171 (1992).

    Google Scholar 

  39. S. D. Shukla (ed.),Platelet Activating Factor Receptor: Signal Mechanisms in Molecular Biology, CRS Press, (1993), p. 84.

  40. J. J. Godfroid, G. Dive, J. Lamotte-Brasseer, et al.,Lipids,26(12), 1161–1166 (1991).

    Google Scholar 

  41. J. Casals-Strenzel,Lipids,26(12), 1157–1167 (1991).

    Google Scholar 

  42. J. Casals-Strenzel,Naunyn-Schmiedeberg's Arch. Pharmacol.,335(3), 351–355 (1987).

    Google Scholar 

  43. US Patent No. 4910194;Ref. Zh. Kghim., 5O69P (1991).

  44. C. M. Chesney, D. D. Pifer, L. M. Cagen,Biochem. Biophys. Res. Commun.,144(1), 359–366 (1987).

    Article  PubMed  CAS  Google Scholar 

  45. Jpn. Patent No. 5017997;Ref. Zh. Khim., 11O175P (1987).

  46. FRG Patent No. 2732931;Ref. Zh. Khim., 24O136P (1979).

  47. US Patent No. 4934240;Ref. Zh. Khim., 10O89P (1992).

  48. Jpn. Patent No. 5543476;Ref. Zh. Khim., 15O138P (1981).

  49. J. Casals-Strenzel, G. Muacevic, and K. Weber,Naunyn-Schmiedeberg's Arch. Pharmacol.,334, 44–48 (1986).

    Google Scholar 

  50. M. A. Sablina, I. P. Ushakova, G. A. Serebinnikova,Khim.-Farm. Zh.,28(6), 9–24 (1994).

    CAS  Google Scholar 

  51. M. Prosdocini, M. Finesso, and E. Dejana,Pharmacol. Res. Commun.,20(1), 1–6 (1988).

    Google Scholar 

  52. É. S. Gabrielyan, S. É. Akopov, and M. R. Grigoryan,Abstracts of Papers. The 6th All-Union Meeting of Pharmacologists [in Russian], Tashkent (1988), p. 76.

  53. C. N. Berry and A. Choppin,Br. J. Pharmacol.,105(Suppl.), 50 (1992).

    Google Scholar 

  54. S. A. Andronati, T. L. Karaseva, V. I. Pawlovsky, et al.,Pharmazie,50(9), 632–634 (1995).

    PubMed  CAS  Google Scholar 

  55. O. V. Demina, P. V. Vrzhets, A. A. Khodonov, et al.,Bioorg. Khim.,21(12), 933–940 (1995).

    PubMed  CAS  Google Scholar 

  56. N. A. Meanwell, P. Hewawasam, J. A. Thomas, et al.,J. Med. Chem.,36, 3251–3264 (1993).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 31, No. 3, pp. 3–9, March, 1997.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andronati, S.A., Karaseva, T.L. Achievements and prospects in the creation of antiaggregative drugs (Review). Pharm Chem J 31, 109–115 (1997). https://doi.org/10.1007/BF02464660

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02464660

Keywords

Navigation